Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Goodwill (2016 - 2022)

Ascendis Pharma A (ASND) has disclosed Goodwill for 7 consecutive years, with $4.9 million as the latest value for Q4 2022.

  • Quarterly Goodwill fell 18.33% to $4.9 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2022, down 18.33% year-over-year, with the annual reading at $4.9 million for FY2022, 18.33% down from the prior year.
  • Goodwill hit $4.9 million in Q4 2022 for Ascendis Pharma A, down from $6.0 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $6.8 million in Q4 2020 to a low of $3.9 million in Q4 2019.
  • Historically, Goodwill has averaged $5.1 million across 5 years, with a median of $4.9 million in 2022.
  • Biggest five-year swings in Goodwill: surged 76.2% in 2020 and later fell 18.33% in 2022.
  • Year by year, Goodwill stood at $4.0 million in 2018, then fell by 3.02% to $3.9 million in 2019, then soared by 76.2% to $6.8 million in 2020, then dropped by 11.52% to $6.0 million in 2021, then dropped by 18.33% to $4.9 million in 2022.
  • Business Quant data shows Goodwill for ASND at $4.9 million in Q4 2022, $6.0 million in Q4 2021, and $6.8 million in Q4 2020.